DYA Fundamental Analysis - DYNACERT INC

Name: DYNACERT INC (DYA) Stock
Brand: DYNACERT INC
Rating: 3.5 (3 reviews)

Fundamental Rating

Taking everything into account, DYA scores 2 out of 10 in our fundamental rating. DYA was compared to 14 industry peers in the Electrical Equipment industry. DYA may be in some trouble as it scores bad on both profitability and health. DYA has a correct valuation and a medium growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

DYA had negative earnings in the past year.

In the past year DYA has reported a negative cash flow from operations.

DYA had negative earnings in each of the past 5 years.

In the past 5 years DYA always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -242.21%, DYA is doing worse than 85.71% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-242.21%
ROE	N/A
ROIC	N/A

ROA(3y)-201.12%

ROA(5y)-150.07%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

DYA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DYA does not have a ROIC to compare to the WACC, probably because it is not profitable.

DYA has more shares outstanding than it did 1 year ago.

DYA has more shares outstanding than it did 5 years ago.

The debt/assets ratio for DYA is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -34.15, we must say that DYA is in the distress zone and has some risk of bankruptcy.

DYA has a worse Altman-Z score (-34.15) than 92.86% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-34.15

ROIC/WACCN/A

WACC7.72%

2.3 Liquidity

DYA has a Current Ratio of 0.51. This is a bad value and indicates that DYA is not financially healthy enough and could expect problems in meeting its short term obligations.

DYA's Current ratio of 0.51 is on the low side compared to the rest of the industry. DYA is outperformed by 71.43% of its industry peers.

DYA has a Quick Ratio of 0.51. This is a bad value and indicates that DYA is not financially healthy enough and could expect problems in meeting its short term obligations.

DYA has a Quick ratio of 0.24. This is amonst the worse of the industry: DYA underperforms 85.71% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.51
Quick Ratio	0.24

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for DYA have decreased strongly by -58.64% in the last year.

DYA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.18%.

DYA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.61% yearly.

EPS 1Y (TTM)-58.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%10.87%

Revenue 1Y (TTM)15.18%

Revenue growth 3Y28.22%

Revenue growth 5Y8.61%

Sales Q2Q%-92.89%

3.2 Future

Based on estimates for the next years, DYA will show a very strong growth in Earnings Per Share. The EPS will grow by 55.65% on average per year.

The Revenue is expected to grow by 263.86% on average over the next years. This is a very strong growth

EPS Next Y100%

EPS Next 2Y55.65%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year656.55%

Revenue Next 2Y263.86%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

DYA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

The Price/Forward Earnings ratio is 9.41, which indicates a very decent valuation of DYA.

DYA's Price/Forward Earnings ratio is rather cheap when compared to the industry. DYA is cheaper than 85.71% of the companies in the same industry.

DYA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.42.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	9.41

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as DYA's earnings are expected to grow with 55.65% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y55.65%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for DYA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DYNACERT INC

TSX:DYA (11/19/2025, 7:00:00 PM)

0.095

-0.01 (-5%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryElectrical Equipment

Earnings (Last)11-14 2025-11-14

Earnings (Next)03-26 2026-03-26

Inst Owners3.62%

Inst Owner ChangeN/A

Ins Owners6.51%

Ins Owner ChangeN/A

Market Cap48.29M

Revenue(TTM)1.17M

Net Income(TTM)-11.44M

Analysts84

Price Target0.77 (710.53%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	9.41
P/S	41.22
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-0.03

EYN/A

EPS(NY)0.01

Fwd EY10.63%

FCF(TTM)-0.02

FCFYN/A

OCF(TTM)-0.02

OCFYN/A

SpS0

BVpS0

TBVpS0

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-242.21%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-201.12%

ROA(5y)-150.07%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0.25

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	2.34%
Cap/Sales	1.63%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.51
Quick Ratio	0.24
Altman-Z	-34.15

F-Score3

WACC7.72%

ROIC/WACCN/A

Cap/Depr(3y)6.19%

Cap/Depr(5y)101.41%

Cap/Sales(3y)7.56%

Cap/Sales(5y)101.33%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-58.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%10.87%

EPS Next Y100%

EPS Next 2Y55.65%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)15.18%

Revenue growth 3Y28.22%

Revenue growth 5Y8.61%

Sales Q2Q%-92.89%

Revenue Next Year656.55%

Revenue Next 2Y263.86%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-68.8%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year117.62%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-42.56%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-43.95%

OCF growth 3YN/A

OCF growth 5YN/A

DYNACERT INC / DYA.CA FAQ

Can you provide the ChartMill fundamental rating for DYNACERT INC?

ChartMill assigns a fundamental rating of 2 / 10 to DYA.CA.

What is the valuation status for DYA stock?

ChartMill assigns a valuation rating of 4 / 10 to DYNACERT INC (DYA.CA). This can be considered as Fairly Valued.

What is the profitability of DYA stock?

DYNACERT INC (DYA.CA) has a profitability rating of 0 / 10.

How financially healthy is DYNACERT INC?

The financial health rating of DYNACERT INC (DYA.CA) is 0 / 10.

DYNACERT INC (DYA.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

DYNACERT INC / DYA.CA FAQ

Can you provide the ChartMill fundamental rating for DYNACERT INC?

What is the valuation status for DYA stock?

What is the profitability of DYA stock?

How financially healthy is DYNACERT INC?